Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals | Zendy

Stéphanie Thébault | Zendy; Nathalie Lejal | Zendy; Alexis Dogliani | Zendy; Amélie Donchet | Zendy; Agathe Urvoas | Zendy; Marie ValerioLepiniec | Zendy; Muriel Lavie | Zendy; Cécile Baronti | Zendy; Franck Touret | Zendy; Bruno R. da Costa | Zendy; Clara Bourgon | Zendy; Audrey Fraysse | Zendy; Audrey Saint-Albin-Deliot | Zendy; Jessica Morel | Zendy; Bernard Klonjkowski | Zendy; Xavier de Lamballerie | Zendy; Jean Dubuisson | Zendy; Alain Roussel | Zendy; Philippe Minard | Zendy; Sophie Le Poder | Zendy; Nicolas Meunier | Zendy; Bernard Delmas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals

Author(s) -

Stéphanie Thébault,

Nathalie Lejal,

Alexis Dogliani,

Amélie Donchet,

Agathe Urvoas,

Marie ValerioLepiniec,

Muriel Lavie,

Cécile Baronti,

Franck Touret,

Bruno R. da Costa,

Clara Bourgon,

Audrey Fraysse,

Audrey Saint-Albin-Deliot,

Jessica Morel,

Bernard Klonjkowski,

Xavier de Lamballerie,

Jean Dubuisson,

Alain Roussel,

Philippe Minard,

Sophie Le Poder,

Nicolas Meunier,

Bernard Delmas

Publication year - 2022

Publication title -

plos pathogens

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.719

H-Index - 206

eISSN - 1553-7374

pISSN - 1553-7366

DOI - 10.1371/journal.ppat.1010799

Subject(s) - covid-19 , spike protein , computational biology , spike (software development) , biology , neuroscience , virology , computer science , medicine , disease , pathology , infectious disease (medical specialty) , software engineering , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research